The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions
Genes · 04.03.2024 · 15 (3) · 332
DOI: 10.3390/genes15030332 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 04.03.2024. Verfasst von Alice Man und 6 weiteren Autor:innen. Beteiligte Einrichtung: Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Hauptthemen laut MEDLINE: Tuberous Sclerosis. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The mechanistic target of rapamycin (mTOR) pathway serves as a master regulator of cell growth, proliferation, and survival. Upregulation of the mTOR pathway has been shown to cause malformations of cortical development, medically refractory epilepsies, and neurodevelopmental disorders, collectively described as mTORopathies. Tuberous sclerosis complex (TSC) serves as the prototypical mTORopathy. Characterized by the development of benign tumors in multiple organs, pathogenic variants in TSC1 or TSC2 disrupt the TSC protein complex, a negative regulator of the mTOR pathway. Variants in critical domains of the TSC complex, especially in the catalytic TSC2 subunit, correlate with increased disease severity. Variants in less crucial exons and non-coding regions, as well as those undetectable with conventional testing, may lead to milder phenotypes. Despite the assumption of complete penetrance, expressivity varies within families, and certain variants delay disease onset with milder neurological effects. Understanding these genotype–phenotype correlations is crucial for effective clinical management. Notably, 15% of patients have no mutation identified by conventional genetic testing, with the majority of cases postulated to be caused by somatic TSC1/TSC2 variants which present complex diagnostic challenges. Advancements in genetic testing, prenatal screening, and precision medicine hold promise for changing the diagnostic and treatment paradigm for TSC and related mTORopathies. Herein, we explore the genetic and molecular mechanisms of TSC and other mTORopathies, emphasizing contemporary genetic methods in understanding and diagnosing the condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.
- Division of Developmental Pediatrics, Department of Pediatrics, McMaster Children's Hospital, Hamilton, ON L8N 3Z5, Canada.
- Division of Genetics, Department of Pediatrics, McMaster University, Hamilton, ON L8S 4L8, Canada.
- Division of Neurology, Department of Pediatrics, McMaster University, Hamilton, ON L8S 4L8, Canada.
ORCID-Profile: Matteo Di Scipio, Yujin Suk, Elisabetta Trinari, Robyn Whitney
Zitieren
APA
Man, A., Di Scipio, M., Grewal, S., Suk, Y., Trinari, E., Ejaz, R., & Whitney, R. (2024). The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions. Genes, 15(3), 332. https://doi.org/10.3390/genes15030332
Vancouver
Man A, Di Scipio M, Grewal S, Suk Y, Trinari E, Ejaz R, et al. The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions. Genes. 2024;15(3):332. doi:10.3390/genes15030332
BibTeX
@article{Man2024,
author = {Man, Alice and Di Scipio, Matteo and Grewal, Shan and Suk, Yujin and Trinari, Elisabetta and Ejaz, Resham and Whitney, Robyn},
title = {The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions},
journal = {Genes},
year = {2024},
volume = {15},
number = {3},
pages = {332},
doi = {10.3390/genes15030332}
}
EUVIMED